From July 1, 2023 to September 14, 2023, the company has repurchased 261,000 shares, representing 0.06% for CNY 5.03 million. With this, the company has completed the repurchase of 1,426,700 shares, representing 0.33% for CNY 30.03 million under the buyback announced on April 25, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.35 CNY | -18.75% |
|
-.--% | -45.40% |
06-25 | Hainan Poly Pharm Gets Nod to Market Voriconazole Injection in Denmark | MT |
06-24 | Hainan Poly Pharm Gets US FDA Marketing Nod for Antibacterial Injection | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.40% | 763M | |
+55.19% | 815B | |
+45.51% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+19.64% | 247B | |
+3.60% | 229B | |
+14.08% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- 300630 Stock
- News Hainan Poly Pharm. Co., Ltd
- Tranche Update on Hainan Poly Pharm. Co., Ltd's Equity Buyback Plan announced on April 25, 2023.